MNBTD
ATRA icon

Moody National Bank Trust Division’s Atara Biotherapeutics ATRA Stock Holding History

Moody National Bank Trust Division’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4
Closed -$3K – 1200
2018
Q4 		$3K Buy
+4
New +$3.71K ﹤0.01% 1056

Other funds holding ATRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moody National Bank Trust Division's ATRA Position: Q1 2019 in Review

Moody National Bank Trust Division sold out of Atara Biotherapeutics (ATRA) in Q1 2019, closing a stake of 4 shares — an estimated $3K sold.

Moody National Bank Trust Division first reported a position in ATRA in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 120 funds tracked by Wall St. Rank hold ATRA as of Q1 2019.

  • Moody National Bank Trust Division reported no remaining Atara Biotherapeutics position as of Q1 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 4 Atara Biotherapeutics shares in Q1 2019, an estimated $3K.
  • Moody National Bank Trust Division first reported a position in Atara Biotherapeutics in Q4 2018 and held it in 1 quarter.
  • Moody National Bank Trust Division's Atara Biotherapeutics position peaked at $3K in Q4 2018.
  • 120 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2019.

Based on Moody National Bank Trust Division's 13F filing for Q1 2019, filed 11 Apr 2019.